Acorda Therapeutics
| Use attributes for filter ! | |
| Web site | www.acorda.com |
|---|---|
| Revenue | 588. 2 million USD (2017) |
| Headquarters | New York |
| United States | |
| Number of employees | 484 (February, 2019) |
| Founders | Ron Cohen |
| Subsidiaries | Biotie Therapies |
| Civitas Therapeutics, Inc. | |
| Biotie Therapies AG | |
| Neuronex, Inc. | |
| Biotie Therapies, Inc. | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 672609 |
About Acorda Therapeutics
Acorda Therapeutics, Inc. is an American biotechnology company based in Ardsley, New York. The company develops therapies that improve neurological function in people with Parkinson's disease, multiple sclerosis and other neurological disorders.
